Abstract
This chapter discusses immune thrombocytopenia. Diagnosis is discussed as well as acute therapy. Patients who fail initial therapy are offered three choices of therapy: splenectomy, thrombopoietin agonists, and rituximab. Evans syndrome and ITP in pregnancy are also discussed.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Bussel J, Arnold DM, Grossbard E, Mayer J, Treliński J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo-controlled trials. Am J Hematol. 2018;93(7):921–30.
Bylsma LC, Fryzek JP, Cetin K, Callaghan F, Bezold C, Mehta B, Wasser JS. Systematic literature review of treatments used for adult immune thrombocytopenia in the second-line setting. Am J Hematol. 2019;94(1):118–32.
Cooper N. State of the art – how I manage immune thrombocytopenia. Br J Haematol. 2017 Apr;177(1):39–54.
Kelton JG, Vrbensky JR, Arnold DM. How do we diagnose immune thrombocytopenia in 2018? Hematology Am Soc Hematol Educ Program. 2018;2018(1):561–7.
Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology Am Soc Hematol Educ Program. 2018;2018(1):568–75.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
DeLoughery, T.G. (2019). Immune Thrombocytopenia. In: DeLoughery, T. (eds) Hemostasis and Thrombosis. Springer, Cham. https://doi.org/10.1007/978-3-030-19330-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-19330-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19329-4
Online ISBN: 978-3-030-19330-0
eBook Packages: MedicineMedicine (R0)